Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa

A phase III, double-blind, randomized, controlled trial (NCT00866619) in sub-Saharan Africa showed RTS,S/AS01 vaccine efficacy against malaria. We now present in-depth safety results from this study. 8922 children (enrolled at 5–17 months) and 6537 infants (enrolled at 6–12 weeks) were 1:1:1-randomi...

Full description

Bibliographic Details
Main Authors:	Guerra Mendoza, Y, Garric, E, Leach, A, Lievens, M, Ofori-Anyinam, O, Pirçon, J, Stegmann, J, Vandoolaeghe, P, Otieno, L, Otieno, W, Owusu-Agyei, S, Sacarlal, J, Masoud, N, Sorgho, H, Tanner, M, Tinto, H, Valea, I, Mtoro, A, Njuguna, P, Oneko, M, Otieno, G, Otieno, K, Gesase, S, Hamel, M, Hoffman, I, Kaali, S, Kamthunzi, P, Kremsner, P, Lanaspa, M, Lell, B, Lusingu, J, Malabeja, A, Aide, P, Akoo, P, Ansong, D, Asante, K, Berkley, J, Adjei, S, Agbenyega, T, Agnandji, S, Schuerman, L
Format:	Journal article
Published:	Taylor and Francis 2019

Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa

Similar Items